It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The human Alzheimer’s disease (AD) brain accumulates angiogenic markers but paradoxically, the cerebral microvasculature is reduced around Aß plaques. Here we demonstrate that angiogenesis is started near Aß plaques in both AD mouse models and human AD samples. However, endothelial cells express the molecular signature of non-productive angiogenesis (NPA) and accumulate, around Aß plaques, a tip cell marker and IB4 reactive vascular anomalies with reduced NOTCH activity. Notably, NPA induction by endothelial loss of presenilin, whose mutations cause familial AD and which activity has been shown to decrease with age, produced a similar vascular phenotype in the absence of Aß pathology. We also show that Aß plaque-associated NPA locally disassembles blood vessels, leaving behind vascular scars, and that microglial phagocytosis contributes to the local loss of endothelial cells. These results define the role of NPA and microglia in local blood vessel disassembly and highlight the vascular component of presenilin loss of function in AD.
Aß are extracellular deposits relevant in Alzheimer’s disease (AD). This study shows that Aß plaques are hubs of endothelial disassembly that induce non-productive angiogenesis. This process is aided by the microglia and unchained by reduced presenilin function, a trait of AD, in endothelial cells.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details















1 Hospital Universitario Virgen del Rocio/CSIC/Universidad de Sevilla, Instituto de Biomedicina de Sevilla (IBiS), Seville, Spain (GRID:grid.414816.e) (ISNI:0000 0004 1773 7922)
2 Hospital Universitario Virgen del Rocio/CSIC/Universidad de Sevilla, Instituto de Biomedicina de Sevilla (IBiS), Seville, Spain (GRID:grid.414816.e) (ISNI:0000 0004 1773 7922); Trinity College of Dublin, D2, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Dublin, Ireland (GRID:grid.8217.c) (ISNI:0000 0004 1936 9705)
3 Hospital Universitario Virgen del Rocio/CSIC/Universidad de Sevilla, Instituto de Biomedicina de Sevilla (IBiS), Seville, Spain (GRID:grid.414816.e) (ISNI:0000 0004 1773 7922); University of Edinburgh, Centre for Inflammation Research, Queen’s Medical Research Institute, Edinburgh, UK (GRID:grid.4305.2) (ISNI:0000 0004 1936 7988)
4 Hospital Universitario Virgen del Rocio/CSIC/Universidad de Sevilla, Instituto de Biomedicina de Sevilla (IBiS), Seville, Spain (GRID:grid.414816.e) (ISNI:0000 0004 1773 7922); Universidad de Sevilla, Department of Biología Celular, Seville, Spain (GRID:grid.9224.d) (ISNI:0000 0001 2168 1229); Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain (GRID:grid.418264.d) (ISNI:0000 0004 1762 4012)
5 Grupo de Neurobiología del Desarrollo-GNDe, Instituto Cajal-CSIC, Madrid, Spain (GRID:grid.419043.b) (ISNI:0000 0001 2177 5516)
6 Grupo de Neurobiología del Desarrollo-GNDe, Instituto Cajal-CSIC, Madrid, Spain (GRID:grid.419043.b) (ISNI:0000 0001 2177 5516); Universidad Europea de Madrid, Departamento de Medicina, Facultad de Ciencias, Biomédicas y de la Salud, Villaviciosa de Odón, Spain (GRID:grid.119375.8) (ISNI:0000000121738416)
7 Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain (GRID:grid.418264.d) (ISNI:0000 0004 1762 4012); Universidad de Malaga, Department of Biologia Celular, Genetica y Fisiologia, Facultad de Ciencias, Instituto de Investigacion Biomedica de Malaga (IBIMA), Malaga, Spain (GRID:grid.10215.37) (ISNI:0000 0001 2298 7828)
8 Consejo Superior de Investigaciones Científicas-Universidad Miguel Hernández (CSIC-UMH), Instituto de Neurociencias de Alicante, Alicante, Spain (GRID:grid.466805.9) (ISNI:0000 0004 1759 6875)
9 Hospital Universitario Virgen del Rocio/CSIC/Universidad de Sevilla, Instituto de Biomedicina de Sevilla (IBiS), Seville, Spain (GRID:grid.414816.e) (ISNI:0000 0004 1773 7922); Universidad de Sevilla, Department of Fisiología Médica y Biofisica, Seville, Spain (GRID:grid.9224.d) (ISNI:0000 0001 2168 1229)
10 Hospital Universitario Virgen del Rocio/CSIC/Universidad de Sevilla, Instituto de Biomedicina de Sevilla (IBiS), Seville, Spain (GRID:grid.414816.e) (ISNI:0000 0004 1773 7922); Universidad de Sevilla, Department of Fisiología Médica y Biofisica, Seville, Spain (GRID:grid.9224.d) (ISNI:0000 0001 2168 1229); Centro de Investigacion Biomedica en Red de Enfermedades Cardiovasculares (CIBER-CV), Madrid, Spain (GRID:grid.413448.e) (ISNI:0000 0000 9314 1427)
11 Department of Hematology and Oncology, Augsburg Medical Center, Augsburg, Germany (GRID:grid.5802.f) (ISNI:0000 0001 1941 7111)
12 University Medical Center Hamburg-Eppendorf, Section of Pneumology, Department of Oncology, Hematology and Stem Cell Transplantation, Hamburg, Germany (GRID:grid.13648.38) (ISNI:0000 0001 2180 3484)
13 Hospital Universitario Virgen del Rocio/CSIC/Universidad de Sevilla, Instituto de Biomedicina de Sevilla (IBiS), Seville, Spain (GRID:grid.414816.e) (ISNI:0000 0004 1773 7922); Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain (GRID:grid.418264.d) (ISNI:0000 0004 1762 4012); Universidad de Sevilla, Department of Fisiología Médica y Biofisica, Seville, Spain (GRID:grid.9224.d) (ISNI:0000 0001 2168 1229)
14 Fundacion CIEN, Madrid, Spain (GRID:grid.10215.37)
15 Hospital Universitario Virgen del Rocio/CSIC/Universidad de Sevilla, Instituto de Biomedicina de Sevilla (IBiS), Seville, Spain (GRID:grid.414816.e) (ISNI:0000 0004 1773 7922); Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain (GRID:grid.418264.d) (ISNI:0000 0004 1762 4012); Universidad de Sevilla, Department of Bioquimica y Biologia Molecular, Facultad de Farmacia, Seville, Spain (GRID:grid.9224.d) (ISNI:0000 0001 2168 1229)